Effect of genetic variation in LRRTM3 on risk of Alzheimer disease

Archives of Neurology

Volumn 69, Issue 7, 2012, Pages 894-900

  Reitz, Christiane ^a,b   Conrad, Christopher ^a   Roszkowski, Katherine ^a   Rogers, Robert S ^b   Mayeux, Richard ^a,b,c  

^a Columbia University ^*  (United States)

^b Vagelos College of Physicians and Surgeons   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; LEUCINE RICH REPEAT TRANSMEMBRANE 3 PROTEIN; MEMBRANE PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; LRRTM3 GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEIN E3; CARIBBEAN REGION; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEK293 CELLS; HISPANIC AMERICANS; HISTONE ACETYLTRANSFERASES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE PROTEINS; MENTAL STATUS SCHEDULE; NATIONAL INSTITUTE ON AGING (U.S.); NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, SMALL INTERFERING; TRANSFECTION; UNITED STATES;

EID: 84863810310     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.2463     Document Type: Article

References (40)

1. Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C. Reconstitution of γ-secretase activity. Nat Cell Biol. 2003;5(5):486-488.
2. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349(6311):704-706. (Pubitemid 21912142)
3. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375(6534):754-760.
4. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995;376(6543):775-778.
5. Majercak J, Ray WJ, Espeseth A, et al. LRRTM3 promotes processing of amyloidprecursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease. Proc Natl Acad Sci U S A. 2006;103(47):17967- 17972. (Pubitemid 44852269)
6. Ertekin-Taner N, Graff-Radford N, Younkin LH, et al. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science. 2000;290(5500):2303-2304. (Pubitemid 32041571)
7. Ertekin-Taner N, Ronald J, Asahara H, et al. Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Hum Mol Genet. 2003;12(23):3133-3143. (Pubitemid 37508884)
8. Martin ER, Bronson PG, Li YJ, et al. Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease. J Med Genet. 2005;42(10):787-792. (Pubitemid 41475256)
9. Liang X, Martin ER, Schnetz-Boutaud N, et al. Effect of heterogeneity on the chromosome 10 risk in late-onset Alzheimer disease. Hum Mutat. 2007;28(11):1065-1073. (Pubitemid 350036910)
10. Edwards TL, Pericak-Vance M, Gilbert JR, Haines JL, Martin ER, Ritchie MD. An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(5):721-735.
11. Bertram L, Mullin K, Parkinson M, et al. Is alpha-T catenin (VR22) an Alzheimer's disease risk gene? J Med Genet. 2007;44(1):e63. doi:10.1136/jmg. 2005.039263.
12. Busby V, Goossens S, Nowotny P, et al. Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease. Neuromolecular Med. 2004;5(2):133-146. (Pubitemid 38596547)
13. Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R; National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group. Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Arch Neurol. 2008;65(11):1518-1526.
14. Lee JH, Cheng R, Barral S, et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol. 2011;68(3):320-328.
15. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol. 1992;49(5):453-460.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
17. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia, PA: Lea & Febiger; 1983.
18. Benton A, ed. FAS Test. Victoria, BC: University of Victoria; 1967.
19. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. Vol 2. Philadelphia, PA: Lea & Febiger; 1983.
20. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York, NY: The Psychological Corporation; 1981.
21. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB, eds. Geriatric Psychiatry. New York, NY: Grune & Stratton; 1976:77-121.
22. Rosen W. The Rosen Drawing Test. Bronx, NY: Veterans Administration Medical Center; 1981.
23. Benton A. The Benton Visual Retention Test. New York, NY: The Psychological Corporation; 1955.
24. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974;24(11):1019-1025.
25. Stricks L, Pittman J, Jacobs DM, Sano M, Stern Y. Normative data for a brief neuropsychological battery administered to English- and Spanish-speaking community- dwelling elders. J Int Neuropsychol Soc. 1998;4(4):311-318. (Pubitemid 28356459)
26. Wilson RS, Bennett DA. Assessment of cognitive decline in old age with brief tests amenable to telephone administration. Neuroepidemiology. 2005;25(1):19-25. (Pubitemid 40864210)
27. Wechsler D. Wechsler Memory Scale-Revised Manual. San Antonio, TX: Psychological Corporation; 1987.
28. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging. 2002;17(2):179-193. (Pubitemid 34568635)
29. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), V: a normative study of the neuropsychological battery. Neurology. 1994;44(4):609-614. (Pubitemid 24129983)
30. Cao X, Südhof TC. Dissection of amyloid-β precursor protein-dependent transcriptional transactivation. J Biol Chem. 2004;279(23):24601-24611. (Pubitemid 38725327)
31. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1-2):279-284. (Pubitemid 33000466)
32. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560. (Pubitemid 37088507)
33. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127(9):820-826. (Pubitemid 27465551)
34. Pritchard JK, Cox NJ. The allelic architecture of human disease genes: common disease-common variant . . . or not? Hum Mol Genet. 2002;11(20):2417- 2423. (Pubitemid 35174705)
35. Vermeire S, Rutgeerts P. Current status of genetics research in inflammatory bowel disease. Genes Immun. 2005;6(8):637-645. (Pubitemid 41741708)
36. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41(10):1088-1093.
37. Lambert JC, Heath S, Even G, et al European Alzheimer's Disease Initiative Investigators. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009;41(10):1094- 1099.
38. Seshadri S, Fitzpatrick AL, Ikram MA, et al CHARGE Consortium; GERAD1 Consortium; EADI1 Consortium. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832-1840.
39. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011;43(5):436-441.
40. Hollingworth P, Harold D, Sims R, et al Alzheimer's Disease Neuroimaging Initiative; CHARGE Consortium; EADI1 Consortium. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011;43(5):429-435.